Abstract
Background: Cancer is the most feared disease, with more than 1.6 million cases yearly. Cancer can start almost anywhere in the human body, from the uncontrollable growth and multiplication of damaged cells. Cancerous tumors can spread into the human body (a process called metastasis) in a solid form usually, but the cancers of the blood generally do not.
Methods: The review analyzes a wide range of scientific literature and research studies to assess the efficacy and mechanisms of action of different inorganic compounds in cancer therapy. It covers both preclinical and clinical studies, examining the effects of these compounds on tumor growth inhibition, apoptosis induction, and modulation of signaling pathways.
Results: Cancer treatment includes chemotherapy, surgery, and radiation. In this article, we will address inorganic compounds as a source of treatment, diagnosis, and carriers of active substances. Overall, this comprehensive review highlights the diverse roles of inorganic compounds in cancer therapy. It emphasizes the importance of further research to better understand the mechanisms of action, optimize dosage regimens, and enhance the clinical efficacy of these compounds in the treatment of cancer.
Conclusion: The findings presented in this review contribute to the development of innovative and effective therapeutic strategies for cancer treatment.
Keywords: cancer; cisplatin; selenium; zinc; copper; gold
This content is restricted to site members. If you are an existing user, please log in. New users may register below.